The growing complexity associated with today’s clinical trials is driving sponsors to deploy non-traditional clinical supply strategies to address their changing needs. Whether they need to develop a more patient-centric strategy to support decentralized trials, meet the demands associated with accelerated approval pathways, or navigate highly complex supply chains for critical therapies, new approaches are needed. This session will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models. 

Speakers:

Aryama Mokoonlall Irmscher
Program Manager, Demand Led Supply, Catalent

Nicole Gray
Director, Decentralized Trial Solutions, Catalent

Trisha Demko
Director, Case Management Services, Catalent